Tuesday, December 12, 2023 · Bob Trebilcock
Following the spinoff of J&J’s consumer brands, Kathy Wengel is strengthening the pharma and med device business’s core technical operations and building a framework for risk management.
Monday, November 7, 2022 · SCMR Staff
What has become clear as we do our post-pandemic reviews is that the firms that demonstrated the ability to get up off the canvas and keep punching were those that invested in resiliency before the pandemic—even if they didn’t use that term.
Thursday, October 13, 2022 · Bob Trebilcock
A conversation with Len DeCandia, Former Global CPO J&J
Thursday, October 13, 2022 · Len DeCandia
In an unpredictable, customer-driven world, we are painfully learning the impact of ignoring enterprise-wide supplier relationships
